Cipla (NSE:CIPLA) Inventories, Finished Goods: ₹35,722 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CIPLA Cipla Ltd NSE:CIPLA
95 GF Score
Price ₹1,438.00
GF Value ₹1,578.04
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipla Inventories, Finished Goods?

Cipla NSE:CIPLA -0.01% 95 Inventories, Finished Goods is ₹35,722 Mil as of Mar. 2026. GuruFocus rates NSE:CIPLA with a GF Score™ of 95/100 and a GF Value™ of ₹1,578.04 (Fairly Valued). The stock has 5 warning signs investors should review.

Cipla's quarterly finished goods stayed the same from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹35,722 Mil).

Cipla's annual finished goods increased from Mar. 2024 (₹26,287 Mil) to Mar. 2025 (₹29,233 Mil) and increased from Mar. 2025 (₹29,233 Mil) to Mar. 2026 (₹35,722 Mil).

Cipla Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Cipla's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla Inventories, Finished Goods Chart

Cipla Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25,599.50 26,440.40 26,287.30 29,232.90 35,722.30

Cipla Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29,232.90 0.00 0.00 0.00 35,722.30
NSE:CIPLA
95GF Score
Cipla Ltd NSE:CIPLA
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipla Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹35,722 Mil mean?
Cipla (NSE:CIPLA) has a Inventories, Finished Goods of ₹35,722 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Cipla and its competitors.
Is Cipla's Inventories, Finished Goods too high?
Cipla's current Inventories, Finished Goods is ₹35,722 Mil. Overall, Cipla has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipla's Inventories, Finished Goods compare to ZTS and UTHR?
Cipla's Inventories, Finished Goods of ₹35,722 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Cipla and its competitors. Cipla's current Inventories, Finished Goods is ₹35,722 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Based on GuruFocus' analysis, Cipla (NSE:CIPLA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,578.04, compared to a current price of ₹1,438.00 — trading 8.9% below its estimated fair value. The current Inventories, Finished Goods is ₹35,722 Mil. Cipla's overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Cipla (NSE:CIPLA), the current Inventories, Finished Goods is ₹35,722 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipla (NSE:CIPLA) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of ₹1,438.00 is trading 8.9% below its estimated GF Value™ of ₹1,578.04. GuruFocus considers Cipla to be Fairly Valued.

Key valuation signals for NSE:CIPLA:

  • Inventories, Finished Goods: ₹35,722 Mil
  • GF Value™: ₹1,578.04 vs. price of ₹1,438.00 (8.9% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the NSE:CIPLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipla Business Description

Other Exchanges 500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
95GF Score

Get the complete analysis for NSE:CIPLA

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,438.00
Price
₹1,578.04
GF Value